Park National Corp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Park National Corp's NVO Position: Q1 2026 in Review
Park National Corp sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,438 shares — an estimated $277K sold.
Park National Corp first reported a position in NVO in Q4 2015 and held it in 18 quarters. The position peaked at $702K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Park National Corp reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Park National Corp sold 5,438 Novo Nordisk shares in Q1 2026, an estimated $277K.
- Park National Corp first reported a position in Novo Nordisk in Q4 2015 and held it in 18 quarters.
- Park National Corp's Novo Nordisk position peaked at $702K in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Park National Corp's 13F filing for Q1 2026, filed 16 Apr 2026.